液相色谱-质谱/质谱联用法测定苯唑西林浓度及其胶囊剂人体生物等效性的研究
目的:建立液相色谱-质谱/质谱联用法( LC-MS/MS)测定人血浆中苯唑西林的浓度,研究苯唑西林钠胶囊与参比制剂苯唑西林钠胶囊(奇菲)的生物等效性。方法:采用随机、单剂量、双交叉对照试验设计,20名男性健康志愿者空腹口服受试及参比制剂1000 mg,采用蛋白沉淀法处理血浆样品,使用LC-MS/MS法测定血浆中苯唑西林的浓度,并以DAS 2.0软件进行方差分析及双单侧t检验,判断2种制剂是否具有生物等效性。结果:口服受试及参比制剂后,血浆中苯唑西林峰浓度(Cmax)分别为(17.0±2.77)、(15.5±3.46)μg/ml;达峰时间(tmax)分别为(0.63±0.14)、(0.72±0....
Saved in:
Published in | 中国医院用药评价与分析 no. 5; pp. 597 - 600 |
---|---|
Main Author | |
Format | Journal Article |
Language | Chinese |
Published |
河北医科大学第二医院药学部,河北石家庄,050000%石药集团中奇制药技术 石家庄 有限公司,河北石家庄,050051
2015
|
Subjects | |
Online Access | Get full text |
ISSN | 1672-2124 |
DOI | 10.14009/j.issn.1672-2124.2015.05.014 |
Cover
Loading…
Abstract | 目的:建立液相色谱-质谱/质谱联用法( LC-MS/MS)测定人血浆中苯唑西林的浓度,研究苯唑西林钠胶囊与参比制剂苯唑西林钠胶囊(奇菲)的生物等效性。方法:采用随机、单剂量、双交叉对照试验设计,20名男性健康志愿者空腹口服受试及参比制剂1000 mg,采用蛋白沉淀法处理血浆样品,使用LC-MS/MS法测定血浆中苯唑西林的浓度,并以DAS 2.0软件进行方差分析及双单侧t检验,判断2种制剂是否具有生物等效性。结果:口服受试及参比制剂后,血浆中苯唑西林峰浓度(Cmax)分别为(17.0±2.77)、(15.5±3.46)μg/ml;达峰时间(tmax)分别为(0.63±0.14)、(0.72±0.26)h;药时曲线下面积(AUC0~6 h)分别为(22.52±4.38)、(22.54±5.79)μg/(ml· h);受试制剂的相对生物利用度为(102.8±19.3)%。结论:受试制剂与市售参比制剂具有生物等效性。 |
---|---|
AbstractList | 目的:建立液相色谱-质谱/质谱联用法( LC-MS/MS)测定人血浆中苯唑西林的浓度,研究苯唑西林钠胶囊与参比制剂苯唑西林钠胶囊(奇菲)的生物等效性。方法:采用随机、单剂量、双交叉对照试验设计,20名男性健康志愿者空腹口服受试及参比制剂1000 mg,采用蛋白沉淀法处理血浆样品,使用LC-MS/MS法测定血浆中苯唑西林的浓度,并以DAS 2.0软件进行方差分析及双单侧t检验,判断2种制剂是否具有生物等效性。结果:口服受试及参比制剂后,血浆中苯唑西林峰浓度(Cmax)分别为(17.0±2.77)、(15.5±3.46)μg/ml;达峰时间(tmax)分别为(0.63±0.14)、(0.72±0.26)h;药时曲线下面积(AUC0~6 h)分别为(22.52±4.38)、(22.54±5.79)μg/(ml· h);受试制剂的相对生物利用度为(102.8±19.3)%。结论:受试制剂与市售参比制剂具有生物等效性。 R965; 目的:建立液相色谱-质谱/质谱联用法( LC-MS/MS)测定人血浆中苯唑西林的浓度,研究苯唑西林钠胶囊与参比制剂苯唑西林钠胶囊(奇菲)的生物等效性。方法:采用随机、单剂量、双交叉对照试验设计,20名男性健康志愿者空腹口服受试及参比制剂1000 mg,采用蛋白沉淀法处理血浆样品,使用LC-MS/MS法测定血浆中苯唑西林的浓度,并以DAS 2.0软件进行方差分析及双单侧t检验,判断2种制剂是否具有生物等效性。结果:口服受试及参比制剂后,血浆中苯唑西林峰浓度(Cmax)分别为(17.0±2.77)、(15.5±3.46)μg/ml;达峰时间(tmax)分别为(0.63±0.14)、(0.72±0.26)h;药时曲线下面积(AUC0~6 h)分别为(22.52±4.38)、(22.54±5.79)μg/(ml· h);受试制剂的相对生物利用度为(102.8±19.3)%。结论:受试制剂与市售参比制剂具有生物等效性。 |
Abstract_FL | OBJECTIVE:To determine human plasma concentration of oxacillin by liquid chromatography -mass spectrometry ( LC-MS/MS ) and study the bioequivalence of the tested and the standard preparations of oxacillin sodium capsules.METHODS:In a randomized, single dose and double crossover design, 20 healthy male volunteers were administered orally with tested and reference oxcillin sodium capsules ( 1 000 mg ) .The plasma samples were treated by of protein precipitation method, and the plasma concentrations of oxacillin within 6 hours after administration were determined by LC-MS/MS;DAS 2.0 software was employed for analysis of variance and two one-sided t-test for evaluation of the bioequivalence of the two preparations.RESULTS: After oral administration of the tested vs. reference preparations, peak plasma concentration (Cmax) of oxacillin stood at (17.0 ±2.77) vs.(15.5 ±3.46) μg/ml, with tmax of (0.63 ±0.14) vs.(0.72 ±0.26) h, and area under the concentration-time curve (AUC0-6 h) of (22.52 ±4.38) vs.(22.54 ±5.79) μg/(ml· h).The relative bioavailability of the tested preparation was (102.8 ± 19.3)%.CONCLUSIONS:The tested oxacillin sodium capsules and the reference preparation are bioequivalent. |
Author | 任进民 王川平 赵曦 董劼 朱辉梅 |
AuthorAffiliation | 河北医科大学第二医院药学部,河北石家庄050000 石药集团中奇制药技术石家庄有限公司,河北石家庄050051 |
AuthorAffiliation_xml | – name: 河北医科大学第二医院药学部,河北石家庄,050000%石药集团中奇制药技术 石家庄 有限公司,河北石家庄,050051 |
Author_FL | ZHAO Xi DONG Jie REN Jinmin ZHU Huimei WANG Chuanping |
Author_FL_xml | – sequence: 1 fullname: REN Jinmin – sequence: 2 fullname: WANG Chuanping – sequence: 3 fullname: ZHAO Xi – sequence: 4 fullname: DONG Jie – sequence: 5 fullname: ZHU Huimei |
Author_xml | – sequence: 1 fullname: 任进民 王川平 赵曦 董劼 朱辉梅 |
BookMark | eNo9kEtLAlEUx-_CIDO_RNCume6de-fOuAzpBUIb9zJPm6FGc4iyVU9odCHhSKBQbSpd9LKUkKIv4zx2fYVuGB0O_A-H3_kf-M-AhFNyDADmEeQRgTCzaPOW6zo8opLACUggvACRyEPWiCRA8n8_DdKua6lQECUoCJgkgR0O-1HnPfb68fMLF791mXx_NCZDfORHfjd8bYWDevDYjutPgX8R336FV5fhoBmM7oJGLTgbxifDoFMLvOPxaDT-bEb-deT1ogcvbJ2Hh_dR-zS68aPecBZMmcqWa6T_NAXyK8v57BqX21hdzy7lOI0SwqkGVjSoY0yQppsZQnUlI6mEYqqKpkElFctIZSLLqmQSlVJF0wyqUcYJig4NnAILE9s9xTEVp1iwS7sVhz0sHBSrrMp21dz_zQeKLB2Gz01wbbPkFHcsdlCuWNtKpVqgVBRFJGOMfwCRrZMp |
ClassificationCodes | R965 |
ContentType | Journal Article |
Copyright | Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
Copyright_xml | – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
DBID | 2RA 92L CQIGP W91 ~WA 2B. 4A8 92I 93N PSX TCJ |
DOI | 10.14009/j.issn.1672-2124.2015.05.014 |
DatabaseName | 维普期刊资源整合服务平台 中文科技期刊数据库-CALIS站点 中文科技期刊数据库-7.0平台 中文科技期刊数据库-医药卫生 中文科技期刊数据库- 镜像站点 Wanfang Data Journals - Hong Kong WANFANG Data Centre Wanfang Data Journals 万方数据期刊 - 香港版 China Online Journals (COJ) China Online Journals (COJ) |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
DocumentTitleAlternate | Determiniation of Oxacillin Concentration in Healthy Volunteers by LC-MS/MS and Bioequivalence Study of Oxacillin Capsules in Human Body |
DocumentTitle_FL | Determiniation of Oxacillin Concentration in Healthy Volunteers by LC-MS/MS and Bioequivalence Study of Oxacillin Capsules in Human Body |
EndPage | 600 |
ExternalDocumentID | zgyyyypjyfx201505014 665551833 |
GroupedDBID | 2RA 92L ALMA_UNASSIGNED_HOLDINGS CDYEO CQIGP W91 ~WA 2B. 4A8 92I 93N ABDBF ACUHS EOJEC OBODZ PSX TCJ TUS |
ID | FETCH-LOGICAL-c644-be3ac0d3341cdf946da97b4636b5fe67b381b67b88b7f4b66acce6c66da2ad0e3 |
ISSN | 1672-2124 |
IngestDate | Thu May 29 04:11:26 EDT 2025 Wed Feb 14 10:30:15 EST 2024 |
IsPeerReviewed | false |
IsScholarly | true |
Issue | 5 |
Keywords | LC-MS/MS Oxacillin Bioequivalence 液相色谱-质谱/质谱联用法 生物等效性 苯唑西林 |
Language | Chinese |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c644-be3ac0d3341cdf946da97b4636b5fe67b381b67b88b7f4b66acce6c66da2ad0e3 |
Notes | Oxacillin;LC-MS/MS;Bioequivalence REN Jinmin, WANG Chuanping, ZHAO Xi, DONG Jie, ZHU Huimei ( 1. Dept. of Pharmacy, The Second Hospital of Hebei Medical Unversity, Hebei Shijiazhuang 050000, China; 2. Zhongqi Pharmaceutical Technology (Shijiazhuang) Co. Ltd. of Shijiazhuang Pharmaceutical Group, Hebei Shijiazhuang 050051, China) OBJECTIVE:To determine human plasma concentration of oxacillin by liquid chromatography -mass spectrometry ( LC-MS/MS ) and study the bioequivalence of the tested and the standard preparations of oxacillin sodium capsules.METHODS:In a randomized, single dose and double crossover design, 20 healthy male volunteers were administered orally with tested and reference oxcillin sodium capsules ( 1 000 mg ) .The plasma samples were treated by of protein precipitation method, and the plasma concentrations of oxacillin within 6 hours after administration were determined by LC-MS/MS;DAS 2.0 software was employed for analysis of variance and two one-sided t-test for evaluation of the bioe |
PageCount | 4 |
ParticipantIDs | wanfang_journals_zgyyyypjyfx201505014 chongqing_primary_665551833 |
PublicationCentury | 2000 |
PublicationDate | 2015 |
PublicationDateYYYYMMDD | 2015-01-01 |
PublicationDate_xml | – year: 2015 text: 2015 |
PublicationDecade | 2010 |
PublicationTitle | 中国医院用药评价与分析 |
PublicationTitleAlternate | Evaluation and Analysis of Drug-use in Hospitals of China |
PublicationTitle_FL | Evaluation and Analysis of Drug-Use in Hospitals of China |
PublicationYear | 2015 |
Publisher | 河北医科大学第二医院药学部,河北石家庄,050000%石药集团中奇制药技术 石家庄 有限公司,河北石家庄,050051 |
Publisher_xml | – name: 河北医科大学第二医院药学部,河北石家庄,050000%石药集团中奇制药技术 石家庄 有限公司,河北石家庄,050051 |
SSID | ssib025702234 ssib017477209 ssib001103637 ssib051368574 ssib000405437 ssib001215202 ssib036441963 ssib006563103 ssib057928707 |
Score | 1.9801582 |
Snippet | 目的:建立液相色谱-质谱/质谱联用法( LC-MS/MS)测定人血浆中苯唑西林的浓度,研究苯唑西林钠胶囊与参比制剂苯唑西林钠胶囊(奇菲)的生物等效性。方法:采用随机、单剂量、双交叉对照试验设计,20名男性健康志愿者空腹口服受试及参比制剂1000... R965; 目的:建立液相色谱-质谱/质谱联用法( LC-MS/MS)测定人血浆中苯唑西林的浓度,研究苯唑西林钠胶囊与参比制剂苯唑西林钠胶囊(奇菲)的生物等效性。方法:采用随机、单剂量、双交叉对照试验设计,20名男性健康志愿者空腹口服受试及参比制剂1000... |
SourceID | wanfang chongqing |
SourceType | Aggregation Database Publisher |
StartPage | 597 |
SubjectTerms | 液相色谱-质谱/质谱联用法 生物等效性 苯唑西林 |
Title | 液相色谱-质谱/质谱联用法测定苯唑西林浓度及其胶囊剂人体生物等效性的研究 |
URI | http://lib.cqvip.com/qk/86765X/201505/665551833.html https://d.wanfangdata.com.cn/periodical/zgyyyypjyfx201505014 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR3LahRBcIgJiBdRVHyTg31RJs7O9PPYvdlFBD1F0FPYeWzEw_qKoDn5BBMPIlkRFNSLmhx8myBB8Wfcx81fsKqnd3bERdRlmKntrq7ueuxM1Wx3tecdiqkMkjRL_JjxzKcig_ugoqkPzkemslTRmOHi5BMn-bFT9Phpdnps4nBp1tKV-XgqWRi5ruR_tAploFdcJfsPmi2IQgHAoF84g4bh_Fc6JjVODBwhqQmiDDGS1CSRypZIYgJiKr6FKNGyKCK1OjFVIuujqqB9hShqKeZV0EFEFLMAI9KQGiO6RpS2yIboOpYAsrLNNSOmjsgKcIRrpSLEMZpojgB0LbUFGDKAdCILMGTDVSkigQ2KreBAYNrSsQNTdQQARysE9DTC2Ck0tGOWAdHCImsiLTs6cHxBE8PLXrklLpFIPgBjAVklBphVREEvYUkgMNppy7XEMxKniGmEoyNrtjkAfCCH4k-hAa6xIq9jbyghGFpliCKQRC5oIKrsaAwMOhqiSJSqsUoBEpqXa0AP2sobBOl2LnfvdfI1rfY3aLsNUbU5q6iqgmeBskN1gqaplSND6aDyoKqKR64YwB8hqUJARSuFCgbZhdVR_QpUZ14ChpXbgbFqC6sB7qURkJCV0Ar6yprLwG50-IsiwRClcJpwRpa34igYsA-UHfBSP_KHERxxWGhdlj8VOLvVVWfJ5n_ZcjmQc5eAi9AHB4-W7oas9Mhn-fxy5z1ym3f3d8cEHpXKeiZIc6qgiXNLWZ46mA49smKe7MLcNfhcOHeteRURA5wEsMmbCIWo4BN8-sypUmgGwVcp1AC3PuLl77iBdSnVH8RxuMXg4HtFUIizh6n8IoyT1DA1H6vgThXDUJEJhVMk7N5VA2Y2e2TA6tE_MYppbM6eb81dBOfcrpVsNRutuZJbP7PN2-ri8Umd31y3e2MLZ3d457rrH3pPPvcXP_Tfvff7n1bg8uPL_Rzo32j32ivdjw-7a_c6bx73773ttB_0X3zrPn3UXVvubLzs3F_q3Fnv31rvPFnqLN78vrHx_etyr_2st7jae73YfXi3e_1V7_Ht3vN2b3V9pzdTr81Uj_luUxo_AZH4cRY1kiCNwPlP0qaiPG0oEWPWxZg1My5iiIBiuEgZiyaNOW8kScYTDnhhIw2yaJc33jrfynZ7k5ymcQoBXZxlkmaNStyopOBwgQvJ40jIYI-3rxDT7IU899As5wxzaEbRHo84wc26J9Ll2VHmsvcv8fZ5WxDO3y7v98bnL13JDkC8NR8ftIb2E1p9JcI |
linkProvider | CAB International |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E6%B6%B2%E7%9B%B8%E8%89%B2%E8%B0%B1-%E8%B4%A8%E8%B0%B1%EF%BC%8F%E8%B4%A8%E8%B0%B1%E8%81%94%E7%94%A8%E6%B3%95%E6%B5%8B%E5%AE%9A%E8%8B%AF%E5%94%91%E8%A5%BF%E6%9E%97%E6%B5%93%E5%BA%A6%E5%8F%8A%E5%85%B6%E8%83%B6%E5%9B%8A%E5%89%82%E4%BA%BA%E4%BD%93%E7%94%9F%E7%89%A9%E7%AD%89%E6%95%88%E6%80%A7%E7%9A%84%E7%A0%94%E7%A9%B6&rft.jtitle=%E4%B8%AD%E5%9B%BD%E5%8C%BB%E9%99%A2%E7%94%A8%E8%8D%AF%E8%AF%84%E4%BB%B7%E4%B8%8E%E5%88%86%E6%9E%90&rft.au=%E4%BB%BB%E8%BF%9B%E6%B0%91&rft.au=%E7%8E%8B%E5%B7%9D%E5%B9%B3&rft.au=%E8%B5%B5%E6%9B%A6&rft.au=%E8%91%A3%E5%8A%BC&rft.date=2015&rft.pub=%E6%B2%B3%E5%8C%97%E5%8C%BB%E7%A7%91%E5%A4%A7%E5%AD%A6%E7%AC%AC%E4%BA%8C%E5%8C%BB%E9%99%A2%E8%8D%AF%E5%AD%A6%E9%83%A8%2C%E6%B2%B3%E5%8C%97%E7%9F%B3%E5%AE%B6%E5%BA%84%2C050000%25%E7%9F%B3%E8%8D%AF%E9%9B%86%E5%9B%A2%E4%B8%AD%E5%A5%87%E5%88%B6%E8%8D%AF%E6%8A%80%E6%9C%AF+%E7%9F%B3%E5%AE%B6%E5%BA%84+%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8%2C%E6%B2%B3%E5%8C%97%E7%9F%B3%E5%AE%B6%E5%BA%84%2C050051&rft.issn=1672-2124&rft.issue=5&rft.spage=597&rft.epage=600&rft_id=info:doi/10.14009%2Fj.issn.1672-2124.2015.05.014&rft.externalDocID=zgyyyypjyfx201505014 |
thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F86765X%2F86765X.jpg http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fzgyyyypjyfx%2Fzgyyyypjyfx.jpg |